Revenue | ₹170.60Cr |
Net Profits | ₹19.98Cr |
Net Profit Margins | 11.71% |
Lincoln Pharmaceuticals Ltd’s revenue fell -0.34% since last year same period to ₹170.60Cr in the Q2 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 0.74% jump in its revenue since last 3-months.
Lincoln Pharmaceuticals Ltd’s net profit fell -24.12% since last year same period to ₹19.98Cr in the Q2 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -27.82% fall in its net profits since last 3-months.
Lincoln Pharmaceuticals Ltd’s net profit margin fell -23.85% since last year same period to 11.71% in the Q2 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -28.35% fall in its net profit margins since last 3-months.
The revenue for Lincoln Pharmaceuticals Ltd in the Q2 results 2025 was ₹170.60Cr.
The net profit for Lincoln Pharmaceuticals Ltd in the Q2 results 2025 was ₹19.98Cr.
The net profit margin for Lincoln Pharmaceuticals Ltd in the Q2 results 2025 was 11.71%.
The revenue for Lincoln Pharmaceuticals Ltd in the Q2 results 2024 was ₹171.19Cr.
The net profit for Lincoln Pharmaceuticals Ltd in the Q2 results 2024 was ₹26.33Cr.
The net profit margin for Lincoln Pharmaceuticals Ltd in the Q2 results 2024 was 15.38%.